You are here: Industry Insights > ART

News List

Distributing HIV drugs using mobile vans increases viral suppression, finds study europeanpharmaceuticalreview
March 13, 2020
Researchers have shown that using mobile vans to deliver and dispense HIV drugs in South Africa and Uganda helps to combat the disease.
Early Antiretroviral Therapy May Not Achieve HIV Remission in Infants drugs
January 20, 2020
Starting antiretroviral therapy (ART) for HIV-infected infants within hours of birth does not seem to result in a higher proportion of infants who attain and sustain viral suppression on ART, according to a study published online January in EClinicalMedic
HIV-Infected Newborns Can Wait Awhile for Treatment drugs
January 16, 2020
The effectiveness of antiretroviral therapy (ART) in newborns with HIV is similar whether it begins within days or within weeks, a new study finds.
Nurses Can Help Manage Drug Interactions in HIV/Hep C Treatment drugs
January 02, 2020
Drug interactions between antiretroviral therapy (ART) and direct-acting antivirals (DAAs) pose a clinical challenge in patients with HIV/hepatitis C virus (HCV) coinfection ...
HIV-Infected Cells Persist in CSF in Individuals on Long-Term ART drugs
July 17, 2019
HIV-Infected Cells Persist in CSF in Individuals on Long-Term ART.
Study finds ART prevents HIV transmission between gay men pharmaceutical-technology
May 05, 2019
A study published in The Lancet has found that taking antiretroviral therapy (ART) stops gay men passing human immunodeficiency virus (HIV) to their partners.
Regular infusions of a novel antibody may suppress HIV for four months europeanpharmaceuticalreview
April 19, 2019
Regular infusions of a novel antibody may suppress HIV for four months.
Knight Therapeutics and Jaguar Health Announce Strategic Partnership pharmafocusasia
December 03, 2018
Knight Therapeutics Inc., a Canadian-based specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription....